ORIGINAL RESEARCH
Phthisiology
doi: 10.25005/2074-0581-2025-27-2-362-372
ARTIFICIAL PNEUMOPERITONEUM IN DESTRUCTIVE PULMONARY TUBERCULOSIS AS AN ADJUNCT TO PULMONARY SURGERY

B.U. SALIKHOV1, E.V. KRASNIKOVA1, V.K. ALIEV1, R.V. TARASOV1,2,3, N.L. KARPINA1, M.A. BAGIROV1,2

1Department of Surgery, Central Scientific Research Institute of Tuberculosis, Moscow, Russian Federation
2Department of Thoracic Surgery named after Academician L.K. Bogush, Russian Medical Academy of Continuing Professional Education, Moscow, Russian Federation
3Department of Surgical Diseases, Branch of "Reaviz Medical University" in Moscow, Moscow, Russian Federation

Objective: To evaluate the effectiveness of artificial pneumoperitoneum (APP) during the perioperative period in patients with destructive pulmonary tuberculosis (PT) who require pneumonectomy (PE) with anterior mediastinal plasty (AMP).

Methods: A cross-sectional prospective-retrospective study included 93 patients with widespread destructive PT who underwent surgical treatment involving PE with AMP. The patients were divided into two groups. The main group consisted of 34 patients who were treated by APP before and after the PE with AMP. In contrast, the control group included 59 patients who underwent PE with AMP without any APP treatment.

Results: Two months after PE with AMP in a single lung, positive radiographic outcomes were observed in 94% (32/34) of patients, compared to 75% (44/59) in the control group (p=0.019). In the late period (6 months) after the operation, positive outcomes were 96% (27/28) and 81% (44/54), respectively (p>0.05).

Conclusion: The radiological data obtained indicate the effectiveness of APP in the perioperative period for patients who underwent PE with AMP

Keywords: Pulmonary tuberculosis, pneumonectomy, pneumoperitoneum, anterior mediastinal plasty.

Download file:

References
  1. Global tuberculosis report 2024. Geneva: World Health Organization; 2024.
  2. Vasilyeva IA, Testov VV, Sterlikov SA. Epidemicheskaya situatsiya po tuberkulyozu v gody pandemii COVID-19 – 2020-2021 gg [Tuberculosis situation in the years of the COVID-19 pandemic – 2020-2021]. Tuberkulyoz i bolezni lyogkikh. 2022;100(3):6-12. https://doi.org/10.21292/2075-1230-2022-100-3-6-12
  3. Galkin V, Sterlikov S, Yablonskiy P. Tendentsii razvitiya epidemicheskoy situatsii po tuberkulyozu vo vremya i posle pandemii COVID-19: Rossiya i SZFO, 2020- 2023 gg [Trends of the tuberculosis epidemical situation during and after the COVID-19 pandemic: Russia and the northwestern federal district, 2020-2023]. Meditsinskiy al'yans. 2024;12(3):6-15. https://doi.org/10.36422/23076348- 2024-12-3-6-15
  4. Fox GJ, Mitnick CD, Benedetti A, Chan ED, Becerra M, Chiang CY, et al. Surgery as an adjunctive treatment for multidrug-resistant tuberculosis: An individual patient data Meta-analysis. Clin Infect Dis. 2016;62(7):887-95. https://doi. org/10.1093/cid/ciw002
  5. Sayir F, Ocakcioglu I, Şehitoğulları A, Çobanoğlu U. Clinical analysis of pneumonectomy for destroyed lung: A retrospective study of 32 patients. Gen Thorac Cardiovasc Surg. 2019;67(6):530-6. https://doi.org/10.1007/s11748- 018-01055-6
  6. Yablonskii PK, Kudriashov GG, Avetisyan AO. Surgical resection in the treatment of pulmonary tuberculosis. Thoracic Surgery Clinics. 2019;29(1):37-46. https:// doi.org/10.1016/j.thorsurg.2018.09.003
  7. Salikhov BU, Krasnikova EV, Lepekha LN, Tarasov RV, Chitorelidze GV, Donchenko DV, i dr. Effektivnost' primeneniya iskusstvennogo pnevmoperitoneuma do i posle pnevmonektomii u bol'nykh rasprostranyonnym destruktivnym tuberkulyozom lyogkikh [The effectiveness of artificial pneumoperitoneum before and after pneumonectomy in patients with advanced destructive pulmonary TB]. Vestnik TSNIIT. 2023;25(4):70-81. https://doi.org/10.57014/2587-6678-2023-7-4-70-81
  8. Chernykh NA, Chumovatov NV, Komissarova OG, Romanov VV. Effektivnost' primeneniya metodov kollapsoterapii v kompleksnom lechenii bol'nykh tuberkulyozom lyogkikh s lekarstvennoy ustoychivost'yu vozbuditelya [Effectiveness of collapse therapies in the complex treatment of pulmonary TB patients with drug resistance]. Vestnik TSNIIT. 2024;8(3):85-92. https://doi. org/10.57014/2587-6678-2024-8-3-85-92
  9. Shapovalov AS, Polezhaev AA, Belov SA. Kollapsoterapiya pri tuberkulyoze lyogkikh: vozvrashchenie k istokam [Collapse therapy in pulmonary tuberculosis: A return to basics]. Tikhookeanskiy meditsinskiy zhurnal. 2017;1:84-7. https:// doi.org/10.17238/PmJ1609-1175.2017.1.84-87
  10. Antoniou M, Chloros D, Spyratos D, Giouleka P, Sichletidis L. Therapeutic pneumoperitoneum in a patient with pulmonary tuberculosis and persistent fever. BMJ Case Rep. 2011;2011:bcr0520102968. https://doi.org/10.1136/ bcr.05.2010.2968
  11. Nitta AT, Iseman MD, Newell JD, Madsen LA, Goble M. Ten-year experience with artificial pneumoperitoneum for end-stage, drug-resistant pulmonary tuberculosis. Clin Infect Dis. 1993;16(2):219-22. https://doi.org/10.1093/ clind/16.2.219
  12. Sheyfer YuA, Zinchuk VV. Vozmozhnye mekhanizmy deystviya iskusstvennogo pnevmotoraksa v lechenii destruktivnykh form tuberkulyoza lyogkikh [Possible mechanisms of action of artificial pneumothorax in the treatment of destructive forms of tuberculosis of lungs]. Novosti mediko-biologicheskikh nauk. 2018;17(1):25-30.
  13. Bаgirov MA, Krаsnikovа EV, Ergeshovа AE, Lovаchevа OV, Kаrpinа NL, Penagi RV. Plastika perednego sredosteniya vo vremya pnevmonektomii kak profilaktika i lechenie mediastinal'nykh gryzh u bol'nykh fibrozno-kavernoznym tuberkulyozom lyogkikh [Anterior mediastinal plastics during pneumonectomy as prevention and treatment of a mediastinal hernia in fibrous cavernous pulmonary tuberculosis patients]. Tuberkulyoz i bolezni lyogkikh. 2017;95(11):36- 40. https://doi.org/10.21292/2075-1230-2017-95-11-36-40
  14. Tarasov RV, Lepekha LN, Bagirov MA. Effektivnost' lecheniya lyogochnykh gryzh s ispol'zovaniem setchatogo implanta u bol'nykh, perenyosshikh pnevmonektomiyu po povodu tuberkulyoza [Effectiveness of treatment for lung hernias using a polymeric mesh implant in patients after pneumonectomy due to TB]. Vestnik TSNIIT. 2023;23(2):73-82. https://doi.org/10.57014/2587-6678- 2023-7-2-73-82
  15. Bogush LK, Mamedbekov EK. Khirurgicheskoe lechenie bol'nykh tuberkulyozom edinstvennogo lyogkogo posle pnevmonektomii [Surgical treatment of patients with single lung tuberculosis after pneumonectomy]. Grudnaya khirurgiya. 1983;1:30-4.
  16. Bogush LK, Zhilin YuN, Kakitelashvili YaV. Anesteziya i reanimatsiya pri operatsiyakh na edinstvennom lyogkom [Anesthesia and resuscitation in operations on a single easy]. Eksperimental'naya khirurgiya i anesteziologiya. 1967;5:70-4.
  17. Giller DB, Imyagozhev YaG, Smerdin SV, Murgustov IB, Kesaev OSh, Koroev VV. Rezektsiya edinstvennogo lyogkogo v lechenii dvustoronnego destruktivnogo tuberkulyoza [Resection of the single lung in the treatment of bilateral destructive tuberculosis]. Tuberkulyoz i bolezni lyogkikh. 2014;7:60-4.
  18. Giller DB, Giller GV, Imyagozhev YaG, Gadzhieva PG, Kesaev OSh, Koroev VV, i dr. Kollapsokhirurgicheskie operatsii v lechenii destruktivnogo tuberkulyoza edinstvennogo lyogkogo [Surgical collapse in the treatment of single lung tuberculosis]. Khirurgiya. Zhurnal im. N.I. Pirogova. 2021;1:15‑21. https://doi. org/10.17116/hirurgia202101115
  19. Elkin AV, Repin MYu, Levashyov YuN. Rezul'taty mestnykh vmeshatel'stv na kaverne u bol'nykh s destruktivnymi formami posleoperatsionnykh retsidivov tuberkulyoza lyogkikh [The results of local interventions on the caverns in patients with destructive forms of postoperative relapses of pulmonary tuberculosis]. Problemy tuberkulyoza i bolezney lyogkikh. 2003;10:21-4.

Authors' information:

Salikhov Bekhruz Umarkulovich,
unior Researcher at the Department of Surgery, Central Scientific Research Institute of Tuberculosis
ORCID ID: 0000-0002-4382-403X
SPIN: 9378-5340
Author ID: 1251303
E-mail: bekhruz80@gmail.com

Krasnikova Elena Vadimovna,
Doctor of Medical Sciences, Head of the 2ⁿd Surgical Department, Central Scientific Research Institute of Tuberculosis
Scopus ID: 57202418243
ORCID ID: 0000-0002-5879-7062
SPIN: 4252-8340
Author ID: 991902
E-mail: el.krasn@gmail.com

Aliev Vilayat Kamalovich,
Candidate of Medical Sciences, Researcher at the Department of Surgery, Central Scientific Research Institute of Tuberculosis
Researcher ID: KEJ-0676-2024
Scopus ID: 57211627863
ORCID ID: 0000-0002-0105-1980
SPIN: 7069-7778
Author ID: 776447
E-mail: vilaliev@gmail.com

Tarasov Ruslan Vyacheslavovich,
Candidate of Medical Sciences, Researcher at the Department of Surgery, Central Scientific Research Institute of Tuberculosis; Assistant of the Department of Thoracic Surgery named after Academician L.K. Bogush, Russian Medical Academy of Continuing Professional Education; Associate Professor of the Department of Surgical Diseases, Branch of "Reaviz Medical University" in Moscow
Scopus ID: 57211623482
ORCID ID: 0000-0001-9498-1142
SPIN: 4245-1560
Author ID: 1025763
E-mail: etavnai@yandex.ru

Karpina Natalya Leonidovna,
Doctor of Medical Sciences, Deputy Director for Scientific Work, Central Scientific Research Institute of Tuberculosis
Scopus ID: 23969485100
ORCID ID: 0000-0001-9337-3903
SPIN: 7919-5280
Author ID: 683869
E-mail: n.karpina@ctri.ru

Bagirov Mamed Adilovich,
Doctor of Medical Sciences, Chief Researcher of the Department of Surgery, Central Scientific Research Institute of Tuberculosis; Professor of the Department of Thoracic Surgery named after Academician L.K. Bogush, Russian Medical Academy of Continuing Professional Education
Scopus ID: 7004190444
ORCID ID: 0000-0001-9788-1024
SPIN: 8820-5448
Author ID: 776474
E-mail: bagirov60@gmail.com

Information about support in the form of grants, equipment, medications

The authors did not receive financial support from manufacturers of medicines and medical equipment

Conflicts of interest: No conflict

Address for correspondence:

Aliev Vilayat Kamalovich
Candidate of Medical Sciences, Researcher at the Department of Surgery, Central Scientific Research Institute of Tuberculosis

107564, Russian Federation, Moscow, Yauzskaya alley, 2

Tel.: +7 (499) 7859196

E-mail: vilaliev@gmail.com


This work is licensed under a Creative Commons Attribution 4.0 International License.

Materials on the topic:
  1. CHARACTERISTICS OF PLEURAL ADHESIONS, OPERATIVE TIME, AND BLOOD LOSS IN PATIENTS OPERATED ON FOR PULMONARY TUBERCULOSIS
  2. RATIONALE FOR THE EFFECTIVE APPLICATION OF THE EXPERIENCE OF ANTI-TUBERCULOSIS CARE SETTINGS DURING THE COVID-19 PANDEMIC
  3. EFFECTIVENESS OF MAGNETIC RESONANCE IMAGING IN THE DIAGNOSIS OF TUBERCULOSIS IN HIV-INFECTED CHILDREN: A CASE REPORT

◄ Back to the list